Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghosn

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Gastroenterology and Hepatology|December 21, 2013
Education and Imaging. Hepatobiliary and pancreatic: peliosis hepatis associated with multiple myelomaR Slim, N Hachem, V Smayra, et al.
Medical Oncology (Northwood, London, England)|December 8, 2010
A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancerM Ghosn, P Aftimos, F S Farhat, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Sarcoidosis and testicular germ cell tumor. Case reportJ P Droz, P Ruffie, G Piot, et al.
Journal De Radiologie|September 6, 2008
[Value of US imaging following mastectomy]H Kanso, H Kazzi, L Menassa-Moussa, et al.
Bulletin Du Cancer|January 1, 1989
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin]S Culine, M Azab, F Pietri, et al.
Presse Medicale (Paris, France : 1983)|July 7, 1990
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin]V Ribrag, J P Droz, C Bouleuc, et al.
Oncology|January 1, 1992
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinomaP Rougier, H Ammarguellat, M Ghosn, et al.
Progress in Clinical and Biological Research|January 1, 1989
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumorsJ P Droz, V Ribrag, M Ghosn, et al.
European Radiology|November 4, 2020
Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenomaE Reizine, M Ronot, M Ghosn, et al.
Seminars in Surgical Oncology|January 1, 1988
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-RoussyJ P Droz, C Theodore, M Ghosn, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Gastroenterology and Hepatology|December 21, 2013
Education and Imaging. Hepatobiliary and pancreatic: peliosis hepatis associated with multiple myelomaR Slim, N Hachem, V Smayra, et al.
Medical Oncology (Northwood, London, England)|December 8, 2010
A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancerM Ghosn, P Aftimos, F S Farhat, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Sarcoidosis and testicular germ cell tumor. Case reportJ P Droz, P Ruffie, G Piot, et al.
Journal De Radiologie|September 6, 2008
[Value of US imaging following mastectomy]H Kanso, H Kazzi, L Menassa-Moussa, et al.
Bulletin Du Cancer|January 1, 1989
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin]S Culine, M Azab, F Pietri, et al.
Presse Medicale (Paris, France : 1983)|July 7, 1990
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin]V Ribrag, J P Droz, C Bouleuc, et al.
Oncology|January 1, 1992
Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinomaP Rougier, H Ammarguellat, M Ghosn, et al.
Progress in Clinical and Biological Research|January 1, 1989
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumorsJ P Droz, V Ribrag, M Ghosn, et al.
European Radiology|November 4, 2020
Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenomaE Reizine, M Ronot, M Ghosn, et al.
Seminars in Surgical Oncology|January 1, 1988
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-RoussyJ P Droz, C Theodore, M Ghosn, et al.
Pageof 6